46 research outputs found

    The role of interleukin 17-mediated immune response in Chagas disease:High level is correlated with better left ventricular function

    Get PDF
    Interleukin 17A (IL-17A) has been associated with protective rather than pathogenic response in Chagas disease (ChD). However, it is not established whether or not IL-17A-mediated immune response is correlated with patient's left ventricular (LV) function in ChD. To address this question we have gathered cardiac functional parameters from ChD patients and analysed the possible relationship between their plasma IL-17A levels and LV function. Plasma IL-17A levels were measured by BD Cytometric Bead Array (CBA) in 240 patients with positive specific serology for Trypanosoma cruzi (T. cruzi) grouped as indeterminate (IND) and Chagas cardiomyopathy (CARD) forms. The levels of IL-17A in ChD patients were compared with 32 healthy individuals, mean age of 39 years, 50% male, that were also included as a control group (non-infected [NI]). The overall mean age of ChD patients was 46 years and 52% were male. The IND group included 95 asymptomatic patients, with ages ranging from 27 to 69 years (mean of 43 years), and 42.1% of them were male. The CARD group included 145 patients, which 58.6% were male, with ages ranging from 23 to 67 years (mean of 49). The IND group presented substantially higher levels of IL-17A, median of 26.16 (3.66-48.33) as compared to both the CARD group, median of 13.89 (3.87-34.54) (P <0.0001), and the NI group, median of 10.78 (6.23-22.26) (P <0.0001). The data analysis demonstrated that the IND group comprises a significantly greater proportion (P <0.001) of high IL-17A producers (52.6%, 50 of 95 subjects) than do the other groups. A significant direct correlation was verified between IL-17A levels and cardiac function expressed by LV ejection fraction (LVEF), LV diastolic diameter (LVDd), and body surface area (BSA)-indexed LVDd as well as ratio of the early diastolic transmitral flow velocity to early diastolic mitral annular velocity (E/e') in both groups. We demonstrated that plasma IL-17A levels has an accurate sensitivity and specificity to predict heart failure in serology-positive patients and might be a useful parameter to distinguish patients with or without cardiac impairment. This study indicates a consistent relationship between high expression of IL-17A and better LV in human chronic ChD. Our data raise the possibility that IL-17A plays an important immunomodulatory role in the chronic phase of ChD and might be involved in protection against myocardial damage

    Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease

    Get PDF
    CD25High CD4+ regulatory T cells (Treg cells) have been described as key players in immune regulation, preventing infection-induced immune pathology and limiting collateral tissue damage caused by vigorous anti-parasite immune response. In this review, we summarize data obtained by the investigation of Treg cells in different clinical forms of Chagas' disease. Ex vivo immunophenotyping of whole blood, as well as after stimulation with Trypanosoma cruzi antigens, demonstrated that individuals in the indeterminate (IND) clinical form of the disease have a higher frequency of Treg cells, suggesting that an expansion of those cells could be beneficial, possibly by limiting strong cytotoxic activity and tissue damage. Additional analysis demonstrated an activated status of Treg cells based on low expression of CD62L and high expression of CD40L, CD69, and CD54 by cells from all chagasic patients after T. cruzi antigenic stimulation. Moreover, there was an increase in the frequency of the population of Foxp3+ CD25HighCD4+ cells that was also IL-10+ in the IND group, whereas in the cardiac (CARD) group, there was an increase in the percentage of Foxp3+ CD25High CD4+ cells that expressed CTLA-4. These data suggest that IL-10 produced by Treg cells is effective in controlling disease development in IND patients. However, in CARD patients, the same regulatory mechanism, mediated by IL-10 and CTLA-4 expression is unlikely to be sufficient to control the progression of the disease. These data suggest that Treg cells may play an important role in controlling the immune response in Chagas' disease and the balance between regulatory and effector T cells may be important for the progression and development of the disease. Additional detailed analysis of the mechanisms on how these cells are activated and exert their function will certainly give insights for the rational design of procedure to achieve the appropriate balance between protection and pathology during parasite infections

    Brazilian Consensus on Photoprotection

    Full text link

    Pacificação e tutela militar na gestão de populaçÔes e territórios

    Full text link

    Perfil clĂ­nico-epidemiolĂłgico de chagĂĄsicos atendidos em ambulatĂłrio de referĂȘncia e proposição de modelo de atenção ao chagĂĄsico na perspectiva do SUS

    No full text
    Estudo caso-controle, para anĂĄlise de caracterĂ­sticas clĂ­nicas e epidemiolĂłgicas foi conduzido em 842 indivĂ­duos atendidos em AmbulatĂłrio de ReferĂȘncia de Doença de Chagas, em Belo Horizonte, no perĂ­odo de 1985/92. Verificou-se que os chagĂĄsicos apresentaram mĂ©dia de idade mais elevada (37,78 anos); menor escolaridade, independente da cor, e desempenhavam atividades de maior esforço (p<0,05). A via vetorial mostrou ser o principal mecanismo de transmissĂŁo. As queixas especĂ­ficas predominaram nos chagĂĄsicos (p<0,05). A ausculta cardĂ­aca (OR:2,29 IC95%: 1,29-4,09) e presença de extra-sĂ­stoles (OR:7,16 IC95%:1,59- 45,07) foram as alteraçÔes mais importantes ao exame clĂ­nico. A IF1 apresentou maior sensibilidade (94%), especificidade (96%); VPP(99%) e VPN(83%). A reação de Elisa realizada em 43 indivĂ­duos nĂŁo mostrou falsos resultados. Houve predomĂ­nio da FCI(56%) ou formas clĂ­nicas iniciais. A importĂąncia de realizar propedĂȘutica mais complexa em situaçÔes especĂ­ficas foi reforçada pelo encontro de ECGs normais e alteração em 30% dos Holter, 41 % dos TE e 33% dos ECOs, alĂ©m de 48% de Rx de tĂłrax normal e ECO alterado. PropĂ”e-se modelo de atenção ao chagĂĄsico integrado no SUS valorizando a confirmação sorolĂłgica, a preparação de recursos humanos capacitados e comprometidos com o desenvolvimento de açÔes integrais de saĂșde e a organização do sistema de referĂȘncia e contra-referĂȘncia, garantindo o acesso do chagĂĄsico aos vĂĄrios nĂ­veis de atenção
    corecore